Thema: US6907321029
ACH, US6907321029
business-163870_1920.jpg - Foto: THN
Accendra Health schedules November 5 results for Accendra Health stock
Analysts cut the target to USD 1.29 on October 23, 2026. Accendra Health stock costs EUR 0.18 on October 27, 2026 after-hours.
ad-hoc-news.de, 27.10.26 19:50 Uhr
ACH, US6907321029
Accendra Health schedules November 5 results for Accendra ...
Q2 revenue was USD 613.23 million, with guidance at USD 2.45 billion to USD 2.55 billion. Accendra Health stock costs EUR 0.19 on October 24, 2026.
ad-hoc-news.de, 24.10.26 19:44 Uhr
ACH, US6907321029
Accendra Health appoints Gardner-Smith before Accendra Health ...
Gardner-Smith began as CEO on October 5, 2026. Accendra Health stock costs EUR 0.22 on October 20, 2026 at 7:35 p.m. CEST.
ad-hoc-news.de, 20.10.26 19:40 Uhr
ACH, US6907321029
Analysts set USD 1.50 target for Accendra Health stock
Accendra Health received six months to cure its October 6, 2026 NYSE notice. Accendra Health stock last stood at USD 0.23 on October 16, 2026.
ad-hoc-news.de, 17.10.26 20:42 Uhr
ACH, US6907321029
Accendra Health stock falls 12.90 percent on NYSE
Accendra Health stock costs EUR 0.24 on October 15, 2026 at 8:44 p.m. CEST, down 12.90 percent on the NYSE. Earnings follow October 29.
ad-hoc-news.de, 15.10.26 20:56 Uhr
ACH, US6907321029
Accendra Health named Gardner-Smith CEO as Accendra Health ...
Second-quarter revenue excluding a payer grew 2.00 percent. Accendra Health stock costs EUR 0.40 on October 8, 2026 after EUR 0.41.
ad-hoc-news.de, 08.10.26 17:24 Uhr
ACH, US6907321029
Accendra Health stock gets a 283,554-share CEO grant
Accendra Health stock closed at USD 0.46 on October 7, down 2.02 percent on the NYSE. Q2 revenue reached USD 613.23 million as guidance stays under pressure.
ad-hoc-news.de, 08.10.26 00:22 Uhr
OMI, US6907321029
Accendra Health names Gardner-Smith CEO: what it means for ...
